Výsledky vyhledávání - Jonathan Treisman
- Zobrazuji výsledky 1 - 3 z 3
-
1
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. Autor Patrick Hwu, GE Shafer, Jonathan Treisman, Daniel Schindler, G. Gross, R Cowherd, Steven A. Rosenberg, Zelig Eshhar
Vydáno 1993Artigo -
2
Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry Autor Mayer Fishman, Janice P. Dutcher, Joseph I. Clark, Ajjai Alva, Gerald Miletello, Brendan D. Curti, Neeraj Agarwal, Ralph J. Hauke, Kathleen M. Mahoney, Hyojeong Moon, Jonathan Treisman, Scott S. Tykodi, Gregory A. Daniels, Michael A. Morse, Michael K. Wong, Howard L. Kaufman, Nancy Gregory, David F. McDermott
Vydáno 2019Artigo -
3
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma Autor Douglas J. Schwartzentruber, David H. Lawson, Jon Richards, Robert M. Conry, Donald M. Miller, Jonathan Treisman, Fawaz Gailani, Lee B. Riley, Kevin C. Conlon, Barbara A. Pockaj, Kari Kendra, Richard L. White, René González, Timothy M. Kuzel, Brendan D. Curti, Phillip D. Leming, Eric D. Whitman, Jai Balkissoon, Douglas S. Reintgen, Howard L. Kaufman, Francesco M. Marincola, Maria J. Merino, Steven A. Rosenberg, Peter L. Choyke, Don Vena, Patrick Hwu
Vydáno 2011Artigo
Vyhledávací nástroje:
Související témata
Cancer
Cancer research
Immune system
Immunology
Immunotherapy
Internal medicine
Medicine
Oncology
Adjuvant
Antibody
Antigen
Biology
CD8
Cancer immunotherapy
Chimeric antigen receptor
Clinical endpoint
Clinical trial
Cytokine
Gastroenterology
Genetics
Interleukin
Interleukin 2
Melanoma
Molecular biology
Monoclonal antibody
Ovarian cancer
Randomized controlled trial
Renal cell carcinoma
Tumor-infiltrating lymphocytes